Current Clinical Trials

 

Saturn Study – AstraZeneca – Phase IIIb study comparing effects of tx with rosuvastatin 40 mg or atorvastatin 80 mg on atherosclerotic disease burden as measured by IVUS in pts. with CAD.

Current/Promote Automaticity IDE Study – St. Jude Medical – A prospective, non-randomized multi-center trial that will be conducted to assess the safety and efficacy of the Promote CRT-D models and Current RF ICD models or other St. Jude Medical ICD/CRT-D system with similar functionality.

ARYx 505 – ARYx Therapeutics – A fib study which is follow-up to the current study which compares Warfarin with study drug. Treatment period is 12 months.

Freedom Study – SJM - Evaluate the benefits of frequent AV/PV and V-V delay optimization using Quick Opt in patients with CRT-D devices.

PREDICT Study – CardioDX –The purpose of this study is to identify a gene expression signature in peripheral blood cells that closely correlates with the presence of clinically significant coronary artery disease as determined by invasive X-ray coronary angiography and/or multi-slice computed tomography coronary angiograph.

Triumph I Study – Lung Rx – Efficacy and tolerability of inhaled treprostinil sodium in patients with severe pulmonary arterial hypertension.

The National Institutes of Health provides a thorough explanation of how clinical trials are conducted and classified. Details for research participants are discussed at http://clinicaltrials.gov/